3
Announcements
Trials
Browse
Landscape
Status
Recruiting
8
Completed
8
Unknown
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Carcinoma, Non-Small-Cell Lung
4
Endometrial Neoplasms
3
Stomach Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lung Neoplasms
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Thrombophilia
1
Thrombocytopenia
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Cancer Extensive Stage
1
Salivary Gland Neoplasms
1
Pathologic Complete Response
1
Papillomavirus Infections
1
Pancreatitis, Chronic
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Myelosuppression
1
Myeloproliferative Disorders
1
Mouth Neoplasms
1
Lymphoma, Non-Hodgkin
1
Leukopenia
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leiomyoma
1
Immunoglobulin G4-Related Disease
1
Hypersplenism
1
Hemoglobinuria, Paroxysmal
1
Hematologic Diseases
1
Growth Hormone-Secreting Pituitary Adenoma
1
Interventions
Exercise
9
Standard of Care
5
trametinib
3
tislelizumab
3
Radiotherapy
3
Radiosurgery
3
Palliative Care
3
Paclitaxel
3
Gemcitabine
3
Carboplatin
3
130-nm albumin-bound paclitaxel
3
trastuzumab deruxtecan
2
cemiplimab
2
Therapeutics
2
Surveys and Questionnaires
2
Resistance Training
2
Oxaliplatin
2
Maintenance
2
Immune Checkpoint Inhibitors
2
Drug Therapy
2
Cisplatin
2
Anastrozole
2
vedolizumab
1
toripalimab
1
surufatinib
1
sparsentan
1
sintilimab
1
semaglutide
1
posaconazole
1
pomalidomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Neoplasms
×
Observation
×
Clear all
NCT07501871
2026-04-21
DMU-CH
Fenerbahce University
Not yet recruiting
80 enrolled